142 related articles for article (PubMed ID: 6547786)
1. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
Abildgaard U; Larsen ML
Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
[TBL] [Abstract][Full Text] [Related]
2. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
3. Laboratory determination of heparin cofactor II.
Ezenagu LC; Brandt JT
Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
[TBL] [Abstract][Full Text] [Related]
4. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
Dupouy D; Sié P; Dol F; Boneu B
Thromb Haemost; 1988 Oct; 60(2):236-9. PubMed ID: 3217919
[TBL] [Abstract][Full Text] [Related]
5. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.
Frantzen Handeland G; Abildgaard U; Aasen AO
Scand J Haematol; 1983 Nov; 31(5):427-36. PubMed ID: 6648356
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
7. Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation.
Andersson TR
Thromb Res; 1987 Apr; 46(2):355-62. PubMed ID: 3603428
[TBL] [Abstract][Full Text] [Related]
8. Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis.
Braunstein KM; Eurenius K
Am J Clin Pathol; 1976 Sep; 66(3):488-94. PubMed ID: 60879
[TBL] [Abstract][Full Text] [Related]
9. [Constitutional dysfunction of heparin cofactor II with a tendency for venous thrombosis].
Marbet GA; Zbinden B; Duckert F
Schweiz Med Wochenschr; 1988 Oct; 118(43):1586-8. PubMed ID: 3238395
[TBL] [Abstract][Full Text] [Related]
10. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
11. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
Hortin GL; Tollefsen DM; Santoro SA
Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
[TBL] [Abstract][Full Text] [Related]
12. Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis.
Delorme MA; Saeed N; Sevcik A; Mitchell L; Berry L; Johnston M; Andrew M
Blood; 1993 Dec; 82(11):3380-5. PubMed ID: 8241508
[TBL] [Abstract][Full Text] [Related]
13. Heparin cofactor II: experimental approach to a new assay and clinical results.
Vinazzer H; Stocker K
Thromb Res; 1991 Feb; 61(3):235-41. PubMed ID: 2028443
[TBL] [Abstract][Full Text] [Related]
14. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
[TBL] [Abstract][Full Text] [Related]
15. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure.
Tollefsen DM; Pestka CA
Blood; 1985 Oct; 66(4):769-74. PubMed ID: 4041618
[TBL] [Abstract][Full Text] [Related]
16. [Standardization of the laboratory method for antithrombin activity measurement].
Okajima K
Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of thrombin-heparin cofactor II complex in plasma from patients with disseminated intravascular coagulation.
Andersson TR; Sie P; Pelzer H; Aamodt LM; Nustad K; Abildgaard U
Thromb Res; 1992 Jun; 66(5):591-8. PubMed ID: 1523613
[TBL] [Abstract][Full Text] [Related]
18. Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy.
Toulon P; Vitoux JF; Capron L; Roncato M; Fiessinger JN; Aiach M
Thromb Res; 1988 Mar; 49(5):497-500. PubMed ID: 3376055
[No Abstract] [Full Text] [Related]
19. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II.
Yamagishi R; Koide T; Sakuragawa N
FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797
[TBL] [Abstract][Full Text] [Related]
20. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
Tollefsen DM; Pestka CA
J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
